These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 31883794)

  • 1. A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.
    Jacob F; Salinas RD; Zhang DY; Nguyen PTT; Schnoll JG; Wong SZH; Thokala R; Sheikh S; Saxena D; Prokop S; Liu DA; Qian X; Petrov D; Lucas T; Chen HI; Dorsey JF; Christian KM; Binder ZA; Nasrallah M; Brem S; O'Rourke DM; Ming GL; Song H
    Cell; 2020 Jan; 180(1):188-204.e22. PubMed ID: 31883794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing.
    Jacob F; Ming GL; Song H
    Nat Protoc; 2020 Dec; 15(12):4000-4033. PubMed ID: 33169003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the potential role of photocurable hydrogel in patient-derived glioblastoma organoid culture through RNA sequencing.
    Liang L; Cui R; Zhong S; Wang Z; He Z; Duan H; Guo X; Lu J; Hu H; Li C; Yu C; Yu Y; Guo C; Mou Y
    Biomater Sci; 2022 Aug; 10(17):4902-4914. PubMed ID: 35861413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoids: A Platform Ready for Glioblastoma Precision Medicine?
    Jin WL; Jin MZ; Tu YY
    Trends Cancer; 2020 Apr; 6(4):265-267. PubMed ID: 32209439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma Model Using Human Cerebral Organoids.
    Ogawa J; Pao GM; Shokhirev MN; Verma IM
    Cell Rep; 2018 Apr; 23(4):1220-1229. PubMed ID: 29694897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion.
    Darrigues E; Zhao EH; De Loose A; Lee MP; Borrelli MJ; Eoff RL; Galileo DS; Penthala NR; Crooks PA; Rodriguez A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomanufacturing of glioblastoma organoids exhibiting hierarchical and spatially organized tumor microenvironment via transdifferentiation.
    Park S; Avera AD; Kim Y
    Biotechnol Bioeng; 2022 Nov; 119(11):3252-3274. PubMed ID: 35869574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biobanking: An Important Resource for Precision Medicine in Glioblastoma.
    Tan SY; Sandanaraj E; Tang C; Ang BT
    Adv Exp Med Biol; 2016; 951():47-56. PubMed ID: 27837553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma.
    Ratliff M; Kim H; Qi H; Kim M; Ku B; Azorin DD; Hausmann D; Khajuria RK; Patel A; Maier E; Cousin L; Ogier A; Sahm F; Etminan N; Bunse L; Winkler F; El-Khoury V; Platten M; Kwon YJ
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived renal cell carcinoma organoids for personalized cancer therapy.
    Li Z; Xu H; Yu L; Wang J; Meng Q; Mei H; Cai Z; Chen W; Huang W
    Clin Transl Med; 2022 Jul; 12(7):e970. PubMed ID: 35802820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening.
    Zhang L; Liu F; Weygant N; Zhang J; Hu P; Qin Z; Yang J; Cheng Q; Fan F; Zeng Y; Tang Y; Li Y; Tang A; He F; Peng J; Liao W; Hu Z; Li M; Liu Z
    Cancer Lett; 2021 Mar; 500():87-97. PubMed ID: 33309780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Derived Organoids of Cholangiocarcinoma.
    Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid models of glioblastoma: advances, applications and challenges.
    Zhang C; Jin M; Zhao J; Chen J; Jin W
    Am J Cancer Res; 2020; 10(8):2242-2257. PubMed ID: 32905502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of glioblastoma organoids and their applications in personalized therapy.
    Xu C; Yuan X; Hou P; Li Z; Wang C; Fang C; Tan Y
    Cancer Biol Med; 2023 Jun; 20(5):353-68. PubMed ID: 37283493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches.
    Shakya S; Gromovsky AD; Hale JS; Knudsen AM; Prager B; Wallace LC; Penalva LOF; Brown HA; Kristensen BW; Rich JN; Lathia JD; Brown JM; Hubert CG
    Acta Neuropathol Commun; 2021 May; 9(1):101. PubMed ID: 34059134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Patient-Derived Glioblastoma with Cerebral Organoids.
    Linkous A; Balamatsias D; Snuderl M; Edwards L; Miyaguchi K; Milner T; Reich B; Cohen-Gould L; Storaska A; Nakayama Y; Schenkein E; Singhania R; Cirigliano S; Magdeldin T; Lin Y; Nanjangud G; Chadalavada K; Pisapia D; Liston C; Fine HA
    Cell Rep; 2019 Mar; 26(12):3203-3211.e5. PubMed ID: 30893594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.
    Gamboa CM; Jara K; Pamarthy S; Liu L; Aiken R; Xiong Z; Danish S; Sabaawy HE
    STAR Protoc; 2021 Mar; 2(1):100345. PubMed ID: 33665625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.
    Calandrini C; Schutgens F; Oka R; Margaritis T; Candelli T; Mathijsen L; Ammerlaan C; van Ineveld RL; Derakhshan S; de Haan S; Dolman E; Lijnzaad P; Custers L; Begthel H; Kerstens HHD; Visser LL; Rookmaaker M; Verhaar M; Tytgat GAM; Kemmeren P; de Krijger RR; Al-Saadi R; Pritchard-Jones K; Kool M; Rios AC; van den Heuvel-Eibrink MM; Molenaar JJ; van Boxtel R; Holstege FCP; Clevers H; Drost J
    Nat Commun; 2020 Mar; 11(1):1310. PubMed ID: 32161258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma.
    Reed MR; Lyle AG; De Loose A; Maddukuri L; Learned K; Beale HC; Kephart ET; Cheney A; van den Bout A; Lee MP; Hundley KN; Smith AM; DesRochers TM; Vibat CRT; Gokden M; Salama S; Wardell CP; Eoff RL; Vaske OM; Rodriguez A
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.